129 related articles for article (PubMed ID: 9779467)
1. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development.
Uhl G; Lin Z; Metzger T; Dar DE
Methods Enzymol; 1998; 296():456-65. PubMed ID: 9779467
[No Abstract] [Full Text] [Related]
2. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
Chen N; Vaughan RA; Reith ME
J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter mutants selectively enhance MPP+ transport.
Kitayama S; Wang JB; Uhl GR
Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
[TBL] [Abstract][Full Text] [Related]
4. Probing structure of neurotransmitter transporters by substituted-cysteine accessibility method.
Javitch JA
Methods Enzymol; 1998; 296():331-46. PubMed ID: 9779459
[No Abstract] [Full Text] [Related]
5. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
Lin Z; Itokawa M; Uhl GR
FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628
[TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.
Lin Z; Wang W; Kopajtic T; Revay RS; Uhl GR
Mol Pharmacol; 1999 Aug; 56(2):434-47. PubMed ID: 10419565
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.
Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR
Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of [3H]dopamine translocation and [3H]cocaine analog binding: a potential screening device for cocaine antagonists.
Reith ME; Xu C; Carroll FI; Chen NH
Methods Enzymol; 1998; 296():248-59. PubMed ID: 9779453
[No Abstract] [Full Text] [Related]
9. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
Lin Z; Wang W; Uhl GR
Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799
[TBL] [Abstract][Full Text] [Related]
10. Cocaine and GBR photoaffinity labels as probes of dopamine transporter structure.
Vaughan RA
Methods Enzymol; 1998; 296():219-30. PubMed ID: 9779451
[TBL] [Abstract][Full Text] [Related]
11. In vivo generation of chimeras.
Buck KJ; Amara SG
Methods Enzymol; 1998; 296():466-75. PubMed ID: 9779468
[No Abstract] [Full Text] [Related]
12. Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells.
Kitayama S; Morita K; Dohi T; Wang JB; Davis SC; Uhl GR
Ann N Y Acad Sci; 1996 Oct; 801():388-93. PubMed ID: 8959052
[No Abstract] [Full Text] [Related]
13. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
[TBL] [Abstract][Full Text] [Related]
14. Molecular model of the neural dopamine transporter.
Ravna AW; Sylte I; Dahl SG
J Comput Aided Mol Des; 2003; 17(5-6):367-82. PubMed ID: 14635728
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of an irreversible dopamine-sparing cocaine antagonist.
Meltzer PC; Liu S; Blanchette H; Blundell P; Madras BK
Bioorg Med Chem; 2002 Nov; 10(11):3583-91. PubMed ID: 12213473
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression.
Wang JB; Moriwaki A; Uhl GR
J Neurochem; 1995 Mar; 64(3):1416-9. PubMed ID: 7861176
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of the dopamine transporter.
Chen N; Reith ME
Eur J Pharmacol; 2000 Sep; 405(1-3):329-39. PubMed ID: 11033338
[TBL] [Abstract][Full Text] [Related]
18. Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter.
Carroll FI; Lewin AH; Boja JW; Kuhar MJ
J Med Chem; 1992 Mar; 35(6):969-81. PubMed ID: 1552510
[No Abstract] [Full Text] [Related]
19. Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter.
Lee SH; Cho HK; Son H; Lee YS
Neuroreport; 1997 Jul; 8(11):2591-4. PubMed ID: 9261833
[TBL] [Abstract][Full Text] [Related]
20. Dopamine uptake by mouse neuroblastoma N1E-115 cells stably expressing human dopamine transporter is differentially inhibited by anti-idiotypic ab2beta antibodies mimicking the configuration of cocaine.
Ho M; Segre M
Brain Res; 2000 Jul; 872(1-2):231-5. PubMed ID: 10924700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
